Life AI Net
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
Hot
تسجيل الدخول
العربية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
تسجيل الدخول
الرئيسية
الأرشيف
الحاسبات
الدليل
More
مباشر
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
الأرشيف
بحث
بحث
الأحدث
الأقدم
مسح
@BioWorld
الإجمالي
1081
المصدر
BioWorld
بحث
--
BioWorld
٨ يناير ٢٠٢٦
Inflarx focuses on izicopan as biopharma spending cuts continue
BioWorld
٨ يناير ٢٠٢٦
Moonlake preps for sonelokimab BLA in HS; no new trials needed
BioWorld
٨ يناير ٢٠٢٦
FDA rejects Vanda’s Hetlioz for jet lag disorder
BioWorld
٨ يناير ٢٠٢٦
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B
BioWorld
٨ يناير ٢٠٢٦
Appeals court says no to cap on indirect costs in NIH grants
BioWorld
٨ يناير ٢٠٢٦
Hetero Labs describes new tyrosine kinase inhibitors
BioWorld
٨ يناير ٢٠٢٦
New 3CLpro inhibitors disclosed in Nxera Pharma patent
BioWorld
٨ يناير ٢٠٢٦
Shanghai Huilun Pharmaceutical discovers new 5-HT2A receptor agonists
BioWorld
٧ يناير ٢٠٢٦
Appointments and advancements for Jan. 7, 2026
BioWorld
٧ يناير ٢٠٢٦
Financings for Jan. 7, 2026
BioWorld
٧ يناير ٢٠٢٦
In the clinic for Jan. 7, 2026
BioWorld
٧ يناير ٢٠٢٦
Other news to note for Jan. 7, 2026
BioWorld
٧ يناير ٢٠٢٦
Regulatory actions for Jan. 7, 2026
BioWorld
٧ يناير ٢٠٢٦
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
BioWorld
٧ يناير ٢٠٢٦
New TNFR1 antagonists disclosed in Dana-Farber Cancer Institute patent
BioWorld
٧ يناير ٢٠٢٦
Chinese scientists discover new GTPase KRAS mutant inhibitors
BioWorld
٧ يناير ٢٠٢٦
Holiday notice
BioWorld
٦ يناير ٢٠٢٦
Appeals court says no to cap on indirect costs in NIH grants
السابق
43 / 61
التالي